Traditional semen analysis and hormonal panels remain foundational diagnostic tools. However, emerging biomarkers provide deeper insight into male reproductive health.
Sperm DNA fragmentation testing, proteomic profiling, seminal plasma metabolomics, and inflammatory cytokine analysis expand diagnostic precision. These tools enable identification of subclinical dysfunction not detectable through conventional testing.
As laboratory technology advances, personalized diagnostic algorithms will refine prognostic accuracy erotic and therapeutic targeting in andrology.
Leave a Reply